News
Co., Ltd., the leader of health enrichment products under BRAND’S trademark in Thailand and Asia, in collaboration with the ...
Greene County Parks and Recreation will unveil its new outdoor fitness playground at 9 a.m. Saturday at Greene County ...
The ACCESS trial is a multicenter, phase 2 trial designed to compare overall survival in patients receiving mismatched unrelated donor peripheral blood stem cells as an allograft source for ...
Writer-director Kip Williams brings a high-tech adaptation of the classic Oscar Wilde story to Broadway. Snook takes on all ...
James Harrison’s legacy is at the heart of a wild story about canny science, boundless goodwill and an errant blood ...
In one small step for robot-kind — thousands of them, really — humanoid robots ran alongside actual humans in a half-marathon ...
The Community’s Foundation announces names of this year’s scholarship recipients and honors those who made the grants ...
Antibody-drug conjugates continue to show benefits in breast cancer, plus the FDA has fast-tracked an innovative AI tool to help identify pancreatic tumors.
17d
MedPage Today on MSNRenal Outcomes Seem to Differ By Gender After Living Kidney DonationAfter living kidney donation, projection of renal function may vary by gender, a retrospective cohort study of 174,311 living kidney donors suggested. Over a median 6.7 months, the incidence rate of ...
The Alumni Wall of Fame Award recognizes UD graduates for outstanding professional and public service achievements, community ...
OncoCyte Corporation’s OCX share price has surged by 12.22%, which has investors questioning if this is right time to sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results